Dapsone and Weight control - a phase IV clinical study of FDA data

Summary:

Weight control is reported as a side effect among people who take Dapsone (dapsone), especially for people who are female, 60+ old, also take Spironolactone, and have Osteoporosis.

The phase IV clinical study analyzes which people have Weight control when taking Dapsone. It is created by eHealthMe based on reports of 11,499 people who have side effects when taking Dapsone from the FDA, and is updated regularly.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.

What is Weight control?

Weight control is found to be associated with 2,095 drugs and 2,318 conditions by eHealthMe. Check the latest studies of Weight control.

On Nov, 17, 2025

11,499 people reported to have side effects when taking Dapsone.
Among them, 29 people (0.25%) have Weight control.

Among these 29 people:

What is the gender of people who have Weight control when taking Dapsone? *

female: 96.55 %
male: 3.45 %

What is the age of people who have Weight control when taking Dapsone? *

What are other drugs people take besides Dapsone? *

What are other side effects people have besides Weight control? *

Pain: 20 people, 68.97%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 65.52%
Fall: 19 people, 65.52%
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 18 people, 62.07%
Wound Infection Pseudomonas: 17 people, 58.62%
Road Traffic Accident: 17 people, 58.62%
Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin)): 17 people, 58.62%
Osteopenia (a condition where bone mineral density is lower than normal): 17 people, 58.62%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 17 people, 58.62%
Glare (difficulty seeing in the presence of bright light): 17 people, 58.62%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 17 people, 58.62%
Constipation: 5 people, 17.24%
Hidradenitis (chronic disease of a type of sweat gland): 3 people, 10.34%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 6.90%
Bone Pain: 2 people, 6.90%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 6.90%
Nausea And Vomiting: 2 people, 6.90%
Nausea (feeling of having an urge to vomit): 2 people, 6.90%
Stress And Anxiety: 2 people, 6.90%
Hypophysitis (inflammation of the pituitary gland): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Dapsone and have Weight control?

- Check whether Weight control is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dapsone:

Dapsone (11,732 reports)

Weight control treatments and more:

Weight control (62,403 reports)

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight control:

Weight control (2,095 drugs)

Browse all the conditions that are associated with Weight control:

Weight control (2,318 conditions)

Related publications that referenced our studies

Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dapsone (the active ingredients of Dapsone) and Dapsone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.